Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Binglian Qingyan spray for acute pharyngitis or acute exacerbation of chronic pharyngitis
ChiCTR-IPR-14005356Phase 4Completed
- Sponsor
- Union Hospital of Huazhong University of Science and Technology
- Start
- Sep 2014
- Countries
- 1
01
Overview
Phase 4, randomised trial of Binglian Qingyan in acute pharyngitis and chronic pharyngitis (3 arms), sponsored by Union Hospital of Huazhong University of Science and Technology. Primary endpoints: sore throat, pharyngeal mucosa irritation and 1 more. Started Sep 2014; status: completed.
02
Drugs
Binglian Qingyan
03
Conditions
acute pharyngitischronic pharyngitis
Beyond the preview
Go deeper on ChiCTR-IPR-14005356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005356.